Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.85 - $6.73 $2,255 - $3,129
-465 Reduced 2.35%
19,339 $96,000
Q2 2024

Aug 14, 2024

BUY
$6.02 - $10.99 $25,585 - $46,707
4,250 Added 27.32%
19,804 $121,000
Q1 2024

May 15, 2024

BUY
$8.82 - $11.12 $137,186 - $172,960
15,554 New
15,554 $172,000
Q1 2023

May 15, 2023

BUY
$7.38 - $10.35 $460,320 - $645,570
62,374 Added 241.14%
88,240 $734,000
Q4 2022

Feb 14, 2023

BUY
$7.63 - $10.22 $86,669 - $116,088
11,359 Added 78.3%
25,866 $248,000
Q3 2022

Nov 14, 2022

BUY
$5.71 - $8.54 $82,834 - $123,889
14,507 New
14,507 $118,000
Q3 2021

Nov 16, 2021

SELL
$6.51 - $9.62 $158,049 - $233,554
-24,278 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$5.96 - $7.85 $144,696 - $190,582
24,278 New
24,278 $177,000
Q3 2020

Nov 17, 2020

SELL
$5.19 - $10.17 $103,260 - $202,342
-19,896 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$5.43 - $9.39 $108,035 - $186,823
19,896 New
19,896 $166,000

Others Institutions Holding FENC

About FENNEC PHARMACEUTICALS INC.


  • Ticker FENC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,067,300
  • Market Cap $165M
  • Description
  • Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...
More about FENC
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.